-
1
-
-
84976479130
-
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
-
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84.
-
(2016)
Hepatology
, vol.64
, pp. 73-84
-
-
Younossi, Z.M.1
Koenig, A.B.2
Abdelatif, D.3
Fazel, Y.4
Henry, L.5
Wymer, M.6
-
3
-
-
78650486196
-
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study
-
Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-131.
-
(2011)
Gastroenterology
, vol.140
, pp. 124-131
-
-
Williams, C.D.1
Stengel, J.2
Asike, M.I.3
Torres, D.M.4
Shaw, J.5
Contreras, M.6
-
4
-
-
84961226869
-
Epidemiology and natural history of non-alcoholic fatty liver disease
-
Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism 2016;65:1017-1025.
-
(2016)
Metabolism
, vol.65
, pp. 1017-1025
-
-
Fazel, Y.1
Koenig, A.B.2
Sayiner, M.3
Goodman, Z.D.4
Younossi, Z.M.5
-
5
-
-
80053581540
-
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
-
Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011;141:1249-1253.
-
(2011)
Gastroenterology
, vol.141
, pp. 1249-1253
-
-
Charlton, M.R.1
Burns, J.M.2
Pedersen, R.A.3
Watt, K.D.4
Heimbach, J.K.5
Dierkhising, R.A.6
-
6
-
-
84923893879
-
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
-
Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015;148:547-555.
-
(2015)
Gastroenterology
, vol.148
, pp. 547-555
-
-
Wong, R.J.1
Aguilar, M.2
Cheung, R.3
Perumpail, R.B.4
Harrison, S.A.5
Younossi, Z.M.6
-
7
-
-
79960029926
-
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
-
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-285.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 274-285
-
-
Vernon, G.1
Baranova, A.2
Younossi, Z.M.3
-
8
-
-
0141510580
-
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
-
Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003;98:2042-2047.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2042-2047
-
-
Harrison, S.A.1
Torgerson, S.2
Hayashi, P.H.3
-
9
-
-
84924938800
-
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies
-
Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 2015;13:643-654.
-
(2015)
Clin Gastroenterol Hepatol
, vol.13
, pp. 643-654
-
-
Singh, S.1
Allen, A.M.2
Wang, Z.3
Prokop, L.J.4
Murad, M.H.5
Loomba, R.6
-
10
-
-
63349097089
-
Liver biopsy
-
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009;49:1017-1044.
-
(2009)
Hepatology
, vol.49
, pp. 1017-1044
-
-
Rockey, D.C.1
Caldwell, S.H.2
Goodman, Z.D.3
Nelson, R.C.4
Smith, A.D.5
-
11
-
-
84944381776
-
Incorporation of noninvasive measures of liver fibrosis into clinical practice: diagnosis and prognosis
-
Asrani SK. Incorporation of noninvasive measures of liver fibrosis into clinical practice: diagnosis and prognosis. Clin Gastroenterol Hepatol 2015;13:2190-2204.
-
(2015)
Clin Gastroenterol Hepatol
, vol.13
, pp. 2190-2204
-
-
Asrani, S.K.1
-
13
-
-
84892881288
-
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
-
Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2014;20:475-485.
-
(2014)
World J Gastroenterol
, vol.20
, pp. 475-485
-
-
Sumida, Y.1
Nakajima, A.2
Itoh, Y.3
-
14
-
-
33750617920
-
Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
-
Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006;44:874-880.
-
(2006)
Hepatology
, vol.44
, pp. 874-880
-
-
Merriman, R.B.1
Ferrell, L.D.2
Patti, M.G.3
Weston, S.R.4
Pabst, M.S.5
Aouizerat, B.E.6
-
15
-
-
20444443042
-
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
-
Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128:1898-1906.
-
(2005)
Gastroenterology
, vol.128
, pp. 1898-1906
-
-
Ratziu, V.1
Charlotte, F.2
Heurtier, A.3
Gombert, S.4
Giral, P.5
Bruckert, E.6
-
16
-
-
0036729447
-
The utility of radiological imaging in nonalcoholic fatty liver disease
-
Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-750.
-
(2002)
Gastroenterology
, vol.123
, pp. 745-750
-
-
Saadeh, S.1
Younossi, Z.M.2
Remer, E.M.3
Gramlich, T.4
Ong, J.P.5
Hurley, M.6
-
17
-
-
80052012241
-
Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis
-
Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011;54:1082-1090.
-
(2011)
Hepatology
, vol.54
, pp. 1082-1090
-
-
Hernaez, R.1
Lazo, M.2
Bonekamp, S.3
Kamel, I.4
Brancati, F.L.5
Guallar, E.6
-
18
-
-
77950874754
-
Liver fat content determined by magnetic resonance imaging and spectroscopy
-
Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF. Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol 2010;16:1560-1566.
-
(2010)
World J Gastroenterol
, vol.16
, pp. 1560-1566
-
-
Springer, F.1
Machann, J.2
Claussen, C.D.3
Schick, F.4
Schwenzer, N.F.5
-
19
-
-
80052996528
-
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
-
Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011;34:729-749.
-
(2011)
J Magn Reson Imaging
, vol.34
, pp. 729-749
-
-
Reeder, S.B.1
Cruite, I.2
Hamilton, G.3
Sirlin, C.B.4
-
20
-
-
84865569519
-
Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial
-
Le TA, Chen J, Changchien C, Peterson MR, Kono Y, Patton H, et al. Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 2012;56:922-932.
-
(2012)
Hepatology
, vol.56
, pp. 922-932
-
-
Le, T.A.1
Chen, J.2
Changchien, C.3
Peterson, M.R.4
Kono, Y.5
Patton, H.6
-
21
-
-
84925339397
-
Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
-
Loomba R, Sirlin CB, Ang B, Bettencourt R, Jain R, Salotti J, et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 2015;61:1239-1250.
-
(2015)
Hepatology
, vol.61
, pp. 1239-1250
-
-
Loomba, R.1
Sirlin, C.B.2
Ang, B.3
Bettencourt, R.4
Jain, R.5
Salotti, J.6
-
22
-
-
85027925485
-
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD
-
Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 2012;36:22-29.
-
(2012)
Aliment Pharmacol Ther
, vol.36
, pp. 22-29
-
-
Permutt, Z.1
Le, T.A.2
Peterson, M.R.3
Seki, E.4
Brenner, D.A.5
Sirlin, C.6
-
23
-
-
84876907610
-
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis
-
Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013;267:422-431.
-
(2013)
Radiology
, vol.267
, pp. 422-431
-
-
Tang, A.1
Tan, J.2
Sun, M.3
Hamilton, G.4
Bydder, M.5
Wolfson, T.6
-
24
-
-
84878274416
-
Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy
-
Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013;267:767-775.
-
(2013)
Radiology
, vol.267
, pp. 767-775
-
-
Idilman, I.S.1
Aniktar, H.2
Idilman, R.3
Kabacam, G.4
Savas, B.5
Elhan, A.6
-
25
-
-
84995360076
-
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice
-
Dulai PS, Sirlin CB, Loomba R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice. J Hepatol 2016;65:1006-1016.
-
(2016)
J Hepatol
, vol.65
, pp. 1006-1016
-
-
Dulai, P.S.1
Sirlin, C.B.2
Loomba, R.3
-
26
-
-
77958154016
-
Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes
-
Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010;36:1825-1835.
-
(2010)
Ultrasound Med Biol
, vol.36
, pp. 1825-1835
-
-
Sasso, M.1
Beaugrand, M.2
de Ledinghen, V.3
Douvin, C.4
Marcellin, P.5
Poupon, R.6
-
27
-
-
85010743428
-
Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease
-
Park CC, Nguyen P, Hernandez C, Bettencourt R, Ramirez K, Fortney L, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 2017;152:598-607.
-
(2017)
Gastroenterology
, vol.152
, pp. 598-607
-
-
Park, C.C.1
Nguyen, P.2
Hernandez, C.3
Bettencourt, R.4
Ramirez, K.5
Fortney, L.6
-
28
-
-
84959449613
-
Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography
-
Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 2016;150:626-637.
-
(2016)
Gastroenterology
, vol.150
, pp. 626-637
-
-
Imajo, K.1
Kessoku, T.2
Honda, Y.3
Tomeno, W.4
Ogawa, Y.5
Mawatari, H.6
-
29
-
-
84856708238
-
The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using FibroScan
-
Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using FibroScan. Clin Res Hepatol Gastroenterol 2012;36:13-20.
-
(2012)
Clin Res Hepatol Gastroenterol
, vol.36
, pp. 13-20
-
-
Sasso, M.1
Miette, V.2
Sandrin, L.3
Beaugrand, M.4
-
30
-
-
84890119533
-
Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population
-
Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim DY, et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int 2014;34:102-109.
-
(2014)
Liver Int
, vol.34
, pp. 102-109
-
-
Chon, Y.E.1
Jung, K.S.2
Kim, S.U.3
Park, J.Y.4
Park, Y.N.5
Kim, D.Y.6
-
31
-
-
85010832078
-
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
-
Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Ledinghen V, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol 2017;66:1022-1030.
-
(2017)
J Hepatol
, vol.66
, pp. 1022-1030
-
-
Karlas, T.1
Petroff, D.2
Sasso, M.3
Fan, J.G.4
Mi, Y.Q.5
de Ledinghen, V.6
-
32
-
-
85020777481
-
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter
-
Wong VW, Petta S, Hiriart JB, Camma C, Wong GL, Marra F, et al. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. J Hepatol 2017;67:577-584.
-
(2017)
J Hepatol
, vol.67
, pp. 577-584
-
-
Wong, V.W.1
Petta, S.2
Hiriart, J.B.3
Camma, C.4
Wong, G.L.5
Marra, F.6
-
33
-
-
33644521965
-
Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations
-
Foucher J, Castera L, Bernard PH, Adhoute X, Laharie D, Bertet J, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006;18:411-412.
-
(2006)
Eur J Gastroenterol Hepatol
, vol.18
, pp. 411-412
-
-
Foucher, J.1
Castera, L.2
Bernard, P.H.3
Adhoute, X.4
Laharie, D.5
Bertet, J.6
-
34
-
-
85020065411
-
Controlled attenuation parameter (CAP) with the XL probe of the FibroScan(R): a comparative study with the M probe and liver biopsy
-
de Lédinghen V, Hiriart JB, Vergniol J, Merrouche W, Bedossa P, Paradis V. Controlled attenuation parameter (CAP) with the XL probe of the FibroScan(R): a comparative study with the M probe and liver biopsy. Dig Dis Sci 2017; doi: 10.1007/s10620-017-4638-3.
-
(2017)
Dig Dis Sci
-
-
de Lédinghen, V.1
Hiriart, J.B.2
Vergniol, J.3
Merrouche, W.4
Bedossa, P.5
Paradis, V.6
-
35
-
-
85011602148
-
Controlled attenuation parameter using the FibroScan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population
-
Chan WK, Nik Mustapha NR, Wong GL, Wong VW, Mahadeva S. Controlled attenuation parameter using the FibroScan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population. United European Gastroenterol J 2017;5:76-85.
-
(2017)
United European Gastroenterol J
, vol.5
, pp. 76-85
-
-
Chan, W.K.1
Nik Mustapha, N.R.2
Wong, G.L.3
Wong, V.W.4
Mahadeva, S.5
-
36
-
-
85038237482
-
Performance characteristics of vibration-controlled transient elastography for evaluation of non-alcoholic fatty liver disease
-
Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, et al. Performance characteristics of vibration-controlled transient elastography for evaluation of non-alcoholic fatty liver disease. Hepatology 2017; doi: 10.1002/hep.29489.
-
(2017)
Hepatology
-
-
Vuppalanchi, R.1
Siddiqui, M.S.2
Van Natta, M.L.3
Hallinan, E.4
Brandman, D.5
Kowdley, K.6
-
37
-
-
84949959656
-
Heritability of hepatic fibrosis and steatosis based on a prospective twin study
-
Loomba R, Schork N, Chen CH, Bettencourt R, Bhatt A, Ang B, et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology 2015;149:1784-1793.
-
(2015)
Gastroenterology
, vol.149
, pp. 1784-1793
-
-
Loomba, R.1
Schork, N.2
Chen, C.H.3
Bettencourt, R.4
Bhatt, A.5
Ang, B.6
-
38
-
-
84929266699
-
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
-
Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 2015;385:956-965.
-
(2015)
Lancet
, vol.385
, pp. 956-965
-
-
Neuschwander-Tetri, B.A.1
Loomba, R.2
Sanyal, A.J.3
Lavine, J.E.4
Van Natta, M.L.5
Abdelmalek, M.F.6
-
39
-
-
84983183920
-
Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
-
Doycheva I, Cui J, Nguyen P, Costa EA, Hooker J, Hofflich H, et al. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. Aliment Pharmacol Ther 2016;43:83-95.
-
(2016)
Aliment Pharmacol Ther
, vol.43
, pp. 83-95
-
-
Doycheva, I.1
Cui, J.2
Nguyen, P.3
Costa, E.A.4
Hooker, J.5
Hofflich, H.6
-
40
-
-
84874115167
-
Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease
-
Patel NS, Peterson MR, Brenner DA, Heba E, Sirlin C, Loomba R. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;37:630-639.
-
(2013)
Aliment Pharmacol Ther
, vol.37
, pp. 630-639
-
-
Patel, N.S.1
Peterson, M.R.2
Brenner, D.A.3
Heba, E.4
Sirlin, C.5
Loomba, R.6
-
41
-
-
84931321456
-
Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study
-
Zarrinpar A, Gupta S, Maurya MR, Subramaniam S, Loomba R. Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study. Gut 2016;65:1546-1554.
-
(2016)
Gut
, vol.65
, pp. 1546-1554
-
-
Zarrinpar, A.1
Gupta, S.2
Maurya, M.R.3
Subramaniam, S.4
Loomba, R.5
-
42
-
-
84992456193
-
Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study
-
Cui J, Chen CH, Lo MT, Schork N, Bettencourt R, Gonzalez MP, et al. Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study. Hepatology 2016;64:1547-1558.
-
(2016)
Hepatology
, vol.64
, pp. 1547-1558
-
-
Cui, J.1
Chen, C.H.2
Lo, M.T.3
Schork, N.4
Bettencourt, R.5
Gonzalez, M.P.6
-
43
-
-
9144249563
-
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis
-
Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-1713.
-
(2003)
Ultrasound Med Biol
, vol.29
, pp. 1705-1713
-
-
Sandrin, L.1
Fourquet, B.2
Hasquenoph, J.M.3
Yon, S.4
Fournier, C.5
Mal, F.6
-
44
-
-
84870819164
-
Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease
-
Wong VW, Vergniol J, Wong GL, Foucher J, Chan AW, Chermak F, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2012;107:1862-1871.
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 1862-1871
-
-
Wong, V.W.1
Vergniol, J.2
Wong, G.L.3
Foucher, J.4
Chan, A.W.5
Chermak, F.6
-
45
-
-
41249100719
-
Non-invasive evaluation of liver fibrosis using transient elastography
-
Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008;48:835-847.
-
(2008)
J Hepatol
, vol.48
, pp. 835-847
-
-
Castera, L.1
Forns, X.2
Alberti, A.3
-
46
-
-
84921785945
-
Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease
-
Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015;274:416-425.
-
(2015)
Radiology
, vol.274
, pp. 416-425
-
-
Tang, A.1
Desai, A.2
Hamilton, G.3
Wolfson, T.4
Gamst, A.5
Lam, J.6
-
47
-
-
85021735463
-
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
-
Caussy C, Soni M, Cui J, Bettencourt R, Schork N, Chen CH, et al. Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis. J Clin Invest 2017;127:2697-2704.
-
(2017)
J Clin Invest
, vol.127
, pp. 2697-2704
-
-
Caussy, C.1
Soni, M.2
Cui, J.3
Bettencourt, R.4
Schork, N.5
Chen, C.H.6
-
48
-
-
84888298670
-
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
-
Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013;58:1930-1940.
-
(2013)
Hepatology
, vol.58
, pp. 1930-1940
-
-
Noureddin, M.1
Lam, J.2
Peterson, M.R.3
Middleton, M.4
Hamilton, G.5
Le, T.A.6
-
49
-
-
84888290605
-
Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis
-
Reeder SB. Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis. Hepatology 2013;58:1877-1880.
-
(2013)
Hepatology
, vol.58
, pp. 1877-1880
-
-
Reeder, S.B.1
-
50
-
-
16244366026
-
Index for rating diagnostic tests
-
Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-35.
-
(1950)
Cancer
, vol.3
, pp. 32-35
-
-
Youden, W.J.1
-
51
-
-
0020083498
-
The meaning and use of the area under a receiver operating characteristic (ROC) curve
-
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
-
(1982)
Radiology
, vol.143
, pp. 29-36
-
-
Hanley, J.A.1
McNeil, B.J.2
-
52
-
-
84867834721
-
Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration
-
Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 2012;36:1011-1014.
-
(2012)
J Magn Reson Imaging
, vol.36
, pp. 1011-1014
-
-
Reeder, S.B.1
Hu, H.H.2
Sirlin, C.B.3
|